Wegovy Pill vs Injection: Which Is Right for You?

Wegovy now comes in two formats: the familiar once-weekly injection, and — from 2026 — a once-daily oral tablet. Both are semaglutide, the same GLP-1 medicine, but the way you take them and the results you can expect are not identical. This guide walks through the honest differences so you can pick the format that fits your life.

Same molecule, two formats

Semaglutide is a GLP-1 receptor agonist. It slows gastric emptying, blunts appetite and helps the brain feel full sooner. The injection delivers it once a week under the skin at a maximum of 2.4mg (or the newer higher 7.2mg dose). The pill delivers the same molecule daily, titrated up to a 25mg maintenance dose. The mechanism is identical; the delivery is not.

How much weight loss can you expect?

• Oral semaglutide 25mg (pill): about 14% average body-weight loss at 64 weeks in OASIS-4, and around 16.6% when taken as prescribed.
• Injectable semaglutide 2.4mg: about 15% average weight loss at 68 weeks in STEP-1.
• Injectable semaglutide 7.2mg (higher dose): up to around 21% in the STEP UP trial in people who reached and maintained the dose (about 18.7% on a treatment-policy basis).

In practical terms, the pill at 25mg and the standard 2.4mg injection sit in the same ballpark. The 7.2mg injection is currently the highest-efficacy semaglutide option.

The rule that makes the pill different

Oral semaglutide is poorly absorbed if there is any food or fluid in the stomach. To work, it must be taken first thing on an empty stomach with no more than a sip of plain water, and then you wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines. The injection has no such rule — you take it once a week at any time of day, with or without food. For some people the daily routine is easier; for others the empty-stomach window is the deal-breaker.

Cardiovascular benefit

The 2.4mg injection is the only weight-loss semaglutide licensed to reduce the risk of heart attack and stroke, based on the SELECT trial. The pill does not have this licensed cardiovascular indication at launch. If you have established cardiovascular disease, that may tip the balance toward the injection.

Side effects

Because the medicine is the same, the side-effect profile is broadly the same: nausea, diarrhoea, constipation, reduced appetite, mostly during dose increases and mostly settling with time. Both formats are titrated slowly for this reason. The pill can occasionally cause more upper-GI symptoms (reflux, early nausea) because absorption happens directly in the stomach; the injection is slightly more likely to be associated with injection-site reactions. Neither is clearly "gentler" for everyone.

Side-by-side comparison

Who suits the pill

• You are needle-averse or genuinely won't self-inject long-term.
• A daily routine (like a morning tablet) fits your life better than a weekly injection.
• You can reliably keep a 30-minute window clear before breakfast, coffee or other medicines.

Who suits the injection

• You want the convenience of once-a-week dosing and no daily food-timing rule.
• You have cardiovascular risk factors and want the licensed CV benefit at 2.4mg.
• You want access to the highest-efficacy semaglutide option (7.2mg) once you've titrated up.

Frequently asked questions

Is the pill as effective as the injection? At its maintenance dose, the pill (~14%) is broadly comparable to the standard 2.4mg injection (~15%). The 7.2mg injection is higher (up to ~21%).

Can I switch from injection to pill? Yes — a pharmacist-led switch is possible, with a fresh titration on the new format. It's a clinical decision, not automatic.

Which has fewer side effects? Neither is clearly gentler. Both are titrated slowly to reduce gut side effects.

Which is cheaper? Pricing varies by dose and pharmacy — at Solira, both formats are priced by dose and include pharmacist review, with no separate consultation fee.